Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
Boris Jülg(Ragon Institute of MGH, MIT and Harvard), Bruce D. Walker(Howard Hughes Medical Institute), George J. Hanna(Merck & Co., Inc., Rahway, NJ, USA (United States)), Holly L. Peay(RTI International), Liza Dawson(National Institute of Allergy and Infectious Diseases), Jeff Taylor(University of North Carolina at Chapel Hill), Katharine J. Bar(California University of Pennsylvania), Joseph J. Eron(University of North Carolina at Chapel Hill), Marina Caskey(Rockefeller University), Deborah Persaud(Johns Hopkins University), Timothy W. Schacker(University of Minnesota), Karine Dubé(University of North Carolina at Chapel Hill), Lynda Dee(AIDS United), Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Nelson L. Michael(Walter Reed Army Institute of Research), Jessica Salzwedel(AIDS Vaccine Advocacy Coalition), Carol D. Weiss(Center for Biologics Evaluation and Research), John W. Mellors(Textron Systems (United Kingdom)), Jonathan Z. Li(Brigham and Women's Hospital), Philip Goulder(Ragon Institute of MGH, MIT and Harvard), John Frater(University of Oxford), Rajesh T. Gandhi(Harvard University), Veronica Miller(University of California, Berkeley), Udom Likhitwonnawut(AIDS Vaccine Advocacy Coalition), Ole S. Søgaard(Aarhus University Hospital), Dan H. Barouch(Beth Israel Deaconess Medical Center), Jintanat Ananworanich(Henry M. Jackson Foundation), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Douglas F. Nixon(Cornell University), Daniel R. Kuritzkes(Brigham and Women's Hospital), David Palm(University of North Carolina at Chapel Hill), Pablo Tebas(University of Pennsylvania), Steven G. Deeks(University of California, San Francisco), Luis J. Montaner(The Wistar Institute), Virginia Sheikh(Center for Drug Evaluation and Research), Karl Salzwedel(National Institute of Allergy and Infectious Diseases), Merlin L. Robb(University of Maryland, Baltimore), Caroline T. Tiemessen(University of the Witwatersrand), Donn Colby(Thai Red Cross Society), Javier Martínez‐Picado(Universitat de Vic - Universitat Central de Catalunya), Rowena Johnston(American Foundation for AIDS Research), Romas Geleziunas(Gilead Sciences (United States)), Serena Spudich(Yale University), Jan van Lunzen(Universidade Federal de São Paulo), Krista L. Dong(Harvard University), Lu Zheng(Harvard University), Giuseppe Pantaleo(University of Lausanne), Randall Tressler(National Institute of Allergy and Infectious Diseases), Richard Jefferys(Utrecht University)
Cited by 206
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k